Ductal carcinoma in situ - Implications for screening mammography

被引：44

作者：

Feig, SA ^{[1
]}

机构：

[1] Mt Sinai Hosp, Mt Sinai Sch Med, Dept Radiol, New York, NY 10029 USA

来源：

RADIOLOGIC CLINICS OF NORTH AMERICA | 2000年 / 38卷 / 04期

关键词：

D O I：

10.1016/S0033-8389(05)70192-5

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Ductal carcinoma in situ (DCIS) now represents 20% of all newly diagnosed breast cancers because of increased detection by screening mammography. Twenty year relative survival rates are 97%. Postsurgical and histological studies and recent molecular biological studies indicate that most cases of DCIS will progress to invasive carcinoma if not detected by mammography. Screening mammography studies support the need for annual versus less frequent screenings to detect DCIS before further progression.

引用

页码：653 / +

页数：17

共 187 条

[1]

ADAMI HO, 1985, CANCER, V55, P643, DOI 10.1002/1097-0142(19850201)55:3<643::AID-CNCR2820550328>3.0.CO

[2]

2-L

[3] Biophenotypes of breast carcinoma in situ defined by image analysis of biological parameters [J].

Albonico, G ;

Querzoli, P ;

Ferretti, S ;

Magri, E ;

Nenci, I .

PATHOLOGY RESEARCH AND PRACTICE, 1996, 192 (02) :117-123

[4]

Allred D C, 1994, Cancer Treat Res, V71, P63

[5] HER-2/NEU IN NODE-NEGATIVE BREAST-CANCER - PROGNOSTIC-SIGNIFICANCE OF OVEREXPRESSION INFLUENCED BY THE PRESENCE OF INSITU CARCINOMA [J].

ALLRED, DC ;

CLARK, GM ;

TANDON, AK ;

MOLINA, R ;

TORMEY, DC ;

OSBORNE, CK ;

GILCHRIST, KW ;

MANSOUR, EG ;

ABELOFF, M ;

EUDEY, L ;

MCGUIRE, WL .

JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (04) :599-605

[6] OVEREXPRESSION OF HER-2 NEU AND ITS RELATIONSHIP WITH OTHER PROGNOSTIC FACTORS CHANGE DURING THE PROGRESSION OF INSITU TO INVASIVE BREAST-CANCER [J].

ALLRED, DC ;

CLARK, GM ;

MOLINA, R ;

TANDON, AK ;

SCHNITT, SJ ;

GILCHRIST, KW ;

OSBORNE, CK ;

TORMEY, DC ;

MCGUIRE, WL .

HUMAN PATHOLOGY, 1992, 23 (09) :974-979

[7] ASSOCIATION OF P53 PROTEIN EXPRESSION WITH TUMOR-CELL PROLIFERATION RATE AND CLINICAL OUTCOME IN NODE-NEGATIVE BREAST-CANCER [J].

ALLRED, DC ;

CLARK, GM ;

ELLEDGE, R ;

FUQUA, SAW ;

BROWN, RW ;

CHAMNESS, GC ;

OSBORNE, CK ;

MCGUIRE, WL .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (03) :200-206

[8] THE PREVALENCE OF CARCINOMA INSITU IN NORMAL AND CANCER-ASSOCIATED BREASTS [J].

ALPERS, CE ;

WELLINGS, SR .

HUMAN PATHOLOGY, 1985, 16 (08) :796-807

[9] C-ERBB-2 ONCOGENE IN BREAST-CANCER - THE RIGHT TARGET OR A DECOY [J].

ANDERSON, TJ .

HUMAN PATHOLOGY, 1992, 23 (09) :971-972

[10]

[Anonymous], 1996, SEER CANC STAT REV 1

← 1 2 3 4 5 6 7 8 9 10 →